Mumbai: It's a breakthrough. A new line of treatment for multi-drug resistant (MDR) tuberculosis has been approved by the US Food and Drug Administration for the first time in 40 years. Tested on 440 patients in the US in two phase-II clinical trials, the drug Sirturo could prove to be a game changer.
